PHA-30057 - Modern Biotherapeutics
Coordinator: Patricia Ragazzon Tel: +44 1782 7 34767
Lecture Time: See Timetable...
Level: Level 6
Credits: 15
Study Hours: 150
School Office:

Programme/Approved Electives for 2024/25

None

Available as a Free Standing Elective

No

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2024/25

Over 40% of the pharmaceutical sector is devoted to a new area called biopharmaceutics. This sector encompasses peptides, proteins, hormones, polymers, stem cells, nucleic acid derived products and much more. Currently a substantial portion of the cosmetic industry is also using biologic products such as hyaluronic acid, collagen and chondroitin.
This module aims to build on existing knowledge and discuss in depth advances in the sector.

Aims
This module aims to build on existing knowledge on biologics taught in previous years in BSc Pharmaceutical Sciences and BSc Pharmaceutical Sciences and Cosmetic, and discuss in depth for the advances in the sector.

Intended Learning Outcomes

critically evaluate the nature and importance of biological products: 2
demonstrate understanding of the possible bottlenecks presented in the industry and how to overcome them: 1,2
critically appraise the mode of action of possible side effects: 2
demonstrate knowledge in all aspects of formulation and manufacturing of biologics: 1

Study hours

Laboratory 4
Tutorials 6
Interactive lectures 20
Lectures 20
The independent study hours (100) will cover exercises, problems, reading and material preparation. Guidelines and materials are provided in KLE.

School Rules

None

Description of Module Assessment

1: Report weighted 40%
Practical skills
a 1000 words laboratory or data-based report evaluating different techniques to monitor the stability and / or production, packaging, presentation and all general information of a biological product

2: Assignment weighted 60%
Case study
a 2000 words assignment critically evaluating a biopharmaceutical (or similar cosmetic biologic) from identification of target, manufacture / formulation /delivery system, mode of action and on each section to use the principles of QbD to identify risks and mitigation steps.